文献速递关节外科

白细胞酯酶试纸检测可预测假体周围关节感染患者再植入后的后续失败

Leukocyte Esterase Strip Test Can Predict Subsequent Failure Following Reimplantation in Patients With Periprosthetic Joint Infection.
PubMed 文献 · J Arthroplasty · 2017-01-26

该单机构研究前瞻性招募并回顾性分析了2009-2016年间109例接受两阶段翻修治疗的假体周围关节感染(PJI)患者,在再植入时进行白细胞酯酶(LE)试纸检测,最终77例纳入分析(平均随访1.76年)。19例(24.7%)出现后续失败,LE检测的灵敏度26.3%、特异度100%、阳性预测值100%、阴性预测值87.5%、AUC 0.632;MSIS标准的对应值分别为25.0%、87.3%、27.6%、85.8%、0.562(特异度P=0.01)。Kaplan-Meier曲线显示再植入时LE阳性患者失败率更高(P<0.001)。结论提示LE阳性可能指示感染持续存在并导致更高的后续失败率。

要点

  • 再植入时LE试纸检测阳性与后续治疗失败率更高相关(P<0.001)。
  • LE检测特异度100%、阳性预测值100%,但灵敏度仅26.3%。
  • LE检测AUC 0.632,MSIS标准AUC 0.562,特异度差异P=0.01。

核心结论

  • 作者认为,对于接受PJI手术治疗的患者,亟需准确的诊断试验来确定最佳再植入时机。
  • 本研究提示,再植入时LE试纸检测阳性可能指示感染持续存在,并导致更高的后续失败率。

研究设计与样本

  • 单机构研究,前瞻性招募并回顾性分析2009-2016年间接受两阶段翻修治疗的PJI患者109例,再植入时行LE试纸检测,LE结果「2+」视为阳性。
  • 95例患者有至少90天随访以评估治疗失败(采用Delphi标准),18例因LE试纸血液污染被排除,最终队列77例(平均随访1.76年)。

主要发现

  • 最终队列中19例(24.7%)出现后续失败。
  • 再植入时LE检测在培养阳性病例中阳性率为22.2%,在培养阴性病例中阳性率为4.4%。
  • LE检测在所有末次随访未失败的患者中均为阴性。
  • LE检测的灵敏度26.3%、特异度100%、阳性预测值100%、阴性预测值87.5%、AUC 0.632;MSIS标准的灵敏度25.0%、特异度87.3%、阳性预测值27.6%、阴性预测值85.8%、AUC 0.562(特异度P=0.01)。
  • Kaplan-Meier曲线显示再植入时LE阳性患者失败率更高(P<0.001)。

关键数值与推荐

  • LE试纸结果「2+」定义为阳性。
  • 治疗失败采用Delphi标准定义。
  • LE检测灵敏度26.3%、特异度100%、阳性预测值100%、阴性预测值87.5%、AUC 0.632。
  • MSIS标准灵敏度25.0%、特异度87.3%、阳性预测值27.6%、阴性预测值85.8%、AUC 0.562(特异度P=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Leukocyte esterase (LE) strip test is an accurate marker for diagnosing periprosthetic joint infection (PJI). This study aims to determine if LE is a good predictor of persistent infection and/or subsequent failure in patients undergoing reimplantation. METHODS: This single-institution study prospectively recruited and retrospectively analyzed 109 patients who underwent two-stage exchange treatment of PJI, from 2009-2016, and had an LE test performed at time of reimplantation. LE results of "2+" were considered positive. Ninety-five patients had 90-day minimum follow-up to assess treatment failure, defined by Delphi criteria. Eighteen patients were excluded due to blood contamination of LE test, resulting in a final cohort of 77 patients (mean follow-up 1.76 years). RESULTS: Of the final cohort, 19 patients (24.7%) experienced subsequent failure. At reimplantation, LE test was positive in 22.2% of culture-positive and 4.4% of culture-negative cases. The LE test was negative in all patients who had not failed at latest follow-up, yielding sensitivity, specificity, positive predictive value, negative predictive value, and AUC of 26.3%, 100%, 100%, 87.5%, and 0.632, respectively; in comparison, MSIS criteria respectively yielded 25.0%, 87.3%, 27.6%, 85.8%, and 0.562 (P = .01 for specificity). Kaplan-Meier curves revealed higher failure rate in patients who had a positive LE test at time of reimplantation (P < .001). CONCLUSION: There is a dire need for an accurate diagnostic test to determine optimal timing of reimplantation in patients undergoing surgical treatment for PJI. The current study suggests that a positive LE test may be indicative of persistence of infection and results in a higher rate of subsequent failure.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kheir MM, Ackerman CT, Tan TL, et al. Leukocyte Esterase Strip Test Can Predict Subsequent Failure Following Reimplantation in Patients With Periprosthetic Joint Infection. J Arthroplasty. 2017. PMID: 28215967. doi:10.1016/j.arth.2017.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。